Tumor Implantation into the Intrahepatic Bile Duct after Percutaneous Ethanol Injection Therapy for Hepatocellular Carcinoma by Tanaka, Shogo et al.
 
Case Rep Gastroenterol 2009;3:395–399 
DOI: 10.1159/000255653 
Published online: November 21, 2009  © 2009 S. Karger AG, Basel 
ISSN 1662–0631 
www.karger.com/crg 
 
 
Shogo Tanaka, MD    Department of Surgery, Ishikiriseiki Hospital, 18–28 Yayoicho 
Higashiosaka 579-8026 (Japan) 
Tel. +81 72 988 3121, Fax +81 72 988 3119, E-Mail m8827074@msic.med.osaka-cu.ac.jp 
 
395
   
Tumor Implantation into the 
Intrahepatic Bile Duct after 
Percutaneous Ethanol Injection 
Therapy for Hepatocellular 
Carcinoma 
Shogo Tanakaa    Takatsugu Yamamotoa    
Nobusuke Fukumotob    Takahiro Uenishic    Kohichi Ohnoa  
Departments of aSurgery and bGastroenterology, Ishikiriseiki Hospital, 
Higashiosaka, and cDepartment of Hepato-Biliary-Pancreatic Surgery, Osaka City 
University Graduate School of Medicine, Osaka, Japan 
 
Key Words 
Seeding · Thrombosis · Needle tract implantation 
 
Abstract 
A 74-year-old man who had undergone transcatheter arterial embolization for hepatitis C 
virus-related hepatocellular carcinoma (Couinaud’s segment III/IV) in April 2003 and 
percutaneous ethanol injection for recurrence at the same site in February 2006 was 
found to have dilation of the intrahepatic bile duct by computed tomography in October 
2008. Contrast-enhanced computed tomography and magnetic resonance 
cholangiopancreatography showed a thrombosis occupying the left hepatic duct to the 
lateral branches with peripheral bile duct dilation. Serum concentration of 
alpha-fetoprotein was elevated. We performed a left hepatectomy under a preoperative 
diagnosis of hepatocellular carcinoma with bile duct invasion. The cut surface of the 
resected specimen showed a tumor thrombosis occupying the region between the left 
hepatic duct and lateral branches, but no tumor in the liver parenchyma. Histologic 
examination showed that the thrombosis in the intrahepatic bile duct was hepatocellular 
carcinoma. Since part of the hepatocellular carcinoma in the region treated with 
percutaneous ethanol injection was adjacent to the tumor thrombosis in the intrahepatic 
bile duct in diagnostic imaging, we diagnosed implantation into the intrahepatic bile 
duct due to percutaneous ethanol injection. The postoperative course was uneventful 
and the patient is doing well without recurrence 8 months after the operation. 
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Introduction 
Needle tract implantation is a rare but well-documented complication following 
percutaneous diagnostic and therapeutic approaches such as biopsy, percutaneous 
ethanol injection (PEI), microwave coagulation therapy, and radiofrequency ablation for 
hepatocellular carcinoma (HCC). The skin, subcutaneous tissue, muscle, peritoneum, and 
liver parenchyma have been reported as sites of implantation [1–4], but implantation into 
the intrahepatic bile duct (IHBD) has not been described previously. We recently 
experienced a patient with tumor seeding in the IHBD after PEI. 
Case Report 
The patient was a 74-year-old man who had undergone transcatheter arterial embolization for 
hepatitis C virus-related HCC (Couinaud’s segment III/IV) in April 2003 and PEI for recurrence at the 
same site in February 2006 (fig. 1a). The patient was found to have dilation of the IHBD by computed 
tomography (CT) in October 2008. Contrast-enhanced CT showed a thrombosis occupying the left 
hepatic duct to the lateral branches with peripheral bile duct dilation (fig. 1b). However, there was no 
tumor in the liver parenchyma, including the region treated by PEI. Magnetic resonance 
cholangiopancreatography revealed a defect of the left hepatic duct caused by the thrombosis with 
dilation of the peripheral lateral branches (fig. 2). Serum concentrations of carcinoembryonic antigen 
and carcinohydrate antigen 19-9 were within the respective reference ranges, but the serum 
concentration of alpha-fetoprotein was elevated (21 mg/ml; normal <6.8 mg/ml). Based on these 
findings, we performed a left hepatic lobectomy under a preoperative diagnosis of HCC with bile duct 
invasion. The cut surface of the resected specimen showed a yellowish tumor thrombosis occupying the 
region between the left hepatic duct and lateral branches (fig. 3), but no tumor in the liver parenchyma. 
Histologic examination showed that the thrombosis in the IHBD was HCC. Since part of the HCC in 
the region treated with PEI was adjacent to the tumor thrombosis in the IHBD in diagnostic imagings, 
we diagnosed HCC implantation into the IHBD due to PEI. The postoperative course was uneventful 
and the patient is doing well without recurrence 8 months after the operation. 
Discussion 
The frequency of needle tract implantation after PEI has been reported to be 
approximately 1% [1, 2]. During percutaneous interventional procedures, viable cancer 
cells that adhere to the needle can be disseminated along the needle tract during removal. 
In addition, blood or fluid refluxing back along the tract may carry cancer cells into the 
peritoneal cavity or to the surface of the skin [5]. However, some reports suggest that 
tumor cells disseminate within the liver rather than along the route of puncture [3, 4], and 
that needle puncture of a tumor through the portal vein may facilitate migration of tumor 
cells from a high-pressure tumor arterial region to the low-pressure portal vein, leading to 
rapid intrahepatic dissemination. In our case, the needle used for PEI might have created 
a pathway along its track between the tumor artery (high pressure) and the IHBD (low 
pressure). Intervals of 5 to 46 months between PEI and development of needle tract 
implantation have been reported [1, 2], whereas intrahepatic dissemination occurring 
1 month after PEI or radiofrequency ablation has been described [3, 4]. In our case, the 
interval after PEI was 32 months, which suggests that growth of the IHBD implantation 
may have been similar to that in needle tract implantation (route of puncture). HCC with 
bile duct invasion has a high risk of intrahepatic recurrence within a few months after 
surgery [6]. Tumor implantation into the IHBD may have different characteristics to 
HCC with bile duct invasion, but we are carefully observing our patient for possible 
recurrence. 
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Fig. 1. a Contrast-enhanced CT performed before PEI in February 2006 demonstrated an intrahepatic 
mass (Couinaud’s segment III/IV) with heterogeneous enhancement. b Contrast-enhanced CT 
performed 32 months after PEI (in October 2008) showed a thrombosis occupying the left hepatic duct 
to the lateral branches (arrow) with peripheral bile duct dilation. 
 
 
 
Fig. 2. Magnetic resonance cholangiopancreatography revealed a defect of the left hepatic duct and 
lateral branches (arrowheads) with peripheral dilation. 
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Fig. 3. The cut surface of the resected specimen showed a yellowish tumor thrombosis occupying a 
region between the left hepatic duct (arrow) and lateral branches (arrowheads). 
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